The 38th Study Session on the Latest Trends in Overseas Medical Devices (June 3, 2026)
AI translatedProgram
Introduction to trends in overseas medical devices, discussions, and articles.
Chairperson: Maruoka Professor Toyo
Deputy Director, Industry-Academia Collaboration Promotion Department, JIHS Clinical Research Center
Professor and Chairman, Department of Oral and Maxillofacial Surgery I , School of Dentistry, Nihon University
Mr. Naoji Fukuda
Professor of Cardiovascular Surgery, Tokyo Medical University
Commentator: Japan Patent Office, Medical Device Certification Specialist
(1) Axogen 's cell-free neuronal allograft " Avance " has been approved as a biological drug in the United States.
Professor Noritoshi Arai Department of Neurology, JIHS National Center for Global Health and Medicine
(2) HeartBeam 's 12- lead ECG data synthesis software has been approved in the United States.
Mr. Hisao Hara Department of Cardiology, JIHS National Center for Global Health and Medicine
(3) Introduction article
Crescom 's AI software for bone age assessment, " MediAI-BA ," has been approved in the United States.